194 related articles for article (PubMed ID: 34282497)
21. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.
Shah N; Martin-Antonio B; Yang H; Ku S; Lee DA; Cooper LJ; Decker WK; Li S; Robinson SN; Sekine T; Parmar S; Gribben J; Wang M; Rezvani K; Yvon E; Najjar A; Burks J; Kaur I; Champlin RE; Bollard CM; Shpall EJ
PLoS One; 2013; 8(10):e76781. PubMed ID: 24204673
[TBL] [Abstract][Full Text] [Related]
22. Multiple effects of IL-21 on human NK cells in ex vivo expansion.
Li Q; Ye LJ; Ren HL; Huyan T; Li J; Shi JL; Huang QS
Immunobiology; 2015 Jul; 220(7):876-88. PubMed ID: 25758713
[TBL] [Abstract][Full Text] [Related]
23. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
[TBL] [Abstract][Full Text] [Related]
24. Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.
Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
Cytotherapy; 2010 Dec; 12(8):1044-55. PubMed ID: 20795758
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
[TBL] [Abstract][Full Text] [Related]
26. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
Peragine N; Torelli GF; Mariglia P; Pauselli S; Vitale A; Guarini A; Foà R
Cancer Immunol Immunother; 2015 Feb; 64(2):201-11. PubMed ID: 25341808
[TBL] [Abstract][Full Text] [Related]
28. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
[TBL] [Abstract][Full Text] [Related]
29. Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Garg TK; Szmania SM; Khan JA; Hoering A; Malbrough PA; Moreno-Bost A; Greenway AD; Lingo JD; Li X; Yaccoby S; Suva LJ; Storrie B; Tricot G; Campana D; Shaughnessy JD; Nair BP; Bellamy WT; Epstein J; Barlogie B; van Rhee F
Haematologica; 2012 Sep; 97(9):1348-56. PubMed ID: 22419581
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
31. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
[TBL] [Abstract][Full Text] [Related]
32. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
33. Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy.
Guo M; Sun C; Qian Y; Zhu L; Ta N; Wang G; Zheng J; Guo F; Liu Y
Front Oncol; 2021; 11():632540. PubMed ID: 33937033
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line.
Shman TV; Vashkevich KP; Migas AA; Matveyenka MA; Lasiukov YA; Mukhametshyna NS; Horbach KI; Aleinikova OV
Clin Exp Med; 2023 Oct; 23(6):2551-2560. PubMed ID: 36527513
[TBL] [Abstract][Full Text] [Related]
35. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation.
Lusty E; Poznanski SM; Kwofie K; Mandur TS; Lee DA; Richards CD; Ashkar AA
Mol Immunol; 2017 Aug; 88():138-147. PubMed ID: 28644973
[TBL] [Abstract][Full Text] [Related]
36. Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapy.
Chang SK; Hou J; Chen GG; Yu DD; Wu HQ; Xie YS; Hu LN; Gao L; Xiao WQ; Kong YY; Tao Y; Shi JM
Neoplasma; 2018 Sep; 65(5):720-729. PubMed ID: 29940772
[TBL] [Abstract][Full Text] [Related]
37. Expansion, purification, and functional assessment of human peripheral blood NK cells.
Somanchi SS; Senyukov VV; Denman CJ; Lee DA
J Vis Exp; 2011 Feb; (48):. PubMed ID: 21339714
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.
Tomchuck SL; Leung WH; Dallas MH
Biol Blood Marrow Transplant; 2015 Jan; 21(1):39-49. PubMed ID: 25464114
[TBL] [Abstract][Full Text] [Related]
39. Effects of interleukin-15 on human CD3(-)CD117(+)CD56(-)OX40L(+) cell differentiation.
Kim S; Han S; Kim MY
Hum Immunol; 2010 Aug; 71(8):745-50. PubMed ID: 20510321
[TBL] [Abstract][Full Text] [Related]
40. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
Front Immunol; 2018; 9():150. PubMed ID: 29456538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
